NCT06075953 2026-03-16
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
Clinical Trials
12 trialsNCT06084338 2025-12-31
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
Phase 2 Recruiting
NCT05011383 2025-07-09
VA-BAT
VA Office of Research and Development
Phase 2 Recruiting
NCT04301765 2025-03-11
TEMEC
Seattle Institute for Biomedical and Clinical Research
Phase 2 Recruiting
NCT03339635 2024-07-30
Short-term Testosterone Replacement in Testicular Cancer Survivors
University Medical Center Groningen
Phase 2 Completed
NCT00587431 2023-11-07
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04492553 2022-11-29
Vitality
Herlev Hospital
Phase 2 Completed
NCT04424654 2022-08-03
PSMA-BAT
Hospital Sirio-Libanes
Phase 2 Completed
NCT01750398 2016-12-05
BAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00586898 2016-03-25
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00853697 2015-10-30
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00577980 2013-04-29
Testosterone in Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn